- Report
- January 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- August 2025
- 184 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- September 2025
- 483 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 186 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 378 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- May 2025
- 110 Pages
Global
From €4189EUR$4,750USD£3,626GBP
- Report
- April 2024
- 160 Pages
Global
From €4382EUR$4,969USD£3,794GBP
- Report
- May 2022
- 167 Pages
Global
From €3175EUR$3,600USD£2,748GBP
- Report
- July 2025
- 45 Pages
Global
From €260EUR$295USD£225GBP
- Book
- April 2022
- 208 Pages
- Book
- November 2020
- 574 Pages
- Book
- August 2018
- 1524 Pages
- Book
- June 2018
- 208 Pages
- Book
- April 2016
- 214 Pages
Global
- Book
- April 2013
- 412 Pages
- Book
- April 2011
- 248 Pages
Global
- Book
- March 2025
- 364 Pages
- Book
- February 2024
- 160 Pages
- Book
- November 2023
- 336 Pages

The Neurodevelopmental market is a subset of Neurology that focuses on the development of the nervous system. It encompasses the diagnosis, treatment, and management of conditions that affect the development of the brain, spinal cord, and peripheral nervous system. This includes conditions such as autism, cerebral palsy, Down syndrome, and intellectual disabilities. Neurodevelopmental disorders can be caused by genetic, environmental, or other factors. Treatment options may include medications, physical therapy, occupational therapy, and speech therapy.
Some companies in the Neurodevelopmental market include AbbVie, Biogen, Novartis, Pfizer, and Shire. These companies develop and market treatments for neurodevelopmental disorders, as well as provide support services for patients and families. Show Less Read more